RCT | Zuranolone outperforms placebo in major depressive disorder treatment
12 May, 2023 | 13:41h | UTCZuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo‐Controlled Phase 3 Trial – The American Journal of Psychiatry (link to abstract – $ for full-text)
Commentary: Zuranolone Found to Quickly Reduce Major Depression Symptoms in Phase 3 Trial – Psychiatric News Alert